Bridge Medicines is a fully funded, professionally staffed biotech company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, ...
The company provides a wide range of drug discovery, manufacturing, testing, and support services including: Animal models, Genetically Engineered Model Services, Drug discovery, Drug safety ...
Our XenoGene™ system enables the discovery of new products by linking the massive amount of "genomic" information generated over the past decade with the chemical compound libraries constructed ...
DeepBiome Therapeutics works at the cutting edge of the microbiome, deep learning, and synthetic biology fields to build a new drug discovery platform.
